A Case of Drug-Induced Liver Injury Secondary to Natalizumab
Joint Authors
Santoiemma, Phillip P.
Maddur, Haripriya
Moore, Christopher M.
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-06-16
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury.
After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab therapy.
American Psychological Association (APA)
Santoiemma, Phillip P.& Maddur, Haripriya& Moore, Christopher M.. 2020. A Case of Drug-Induced Liver Injury Secondary to Natalizumab. Case Reports in Hepatology،Vol. 2020, no. 2020, pp.1-2.
https://search.emarefa.net/detail/BIM-1147943
Modern Language Association (MLA)
Santoiemma, Phillip P.…[et al.]. A Case of Drug-Induced Liver Injury Secondary to Natalizumab. Case Reports in Hepatology No. 2020 (2020), pp.1-2.
https://search.emarefa.net/detail/BIM-1147943
American Medical Association (AMA)
Santoiemma, Phillip P.& Maddur, Haripriya& Moore, Christopher M.. A Case of Drug-Induced Liver Injury Secondary to Natalizumab. Case Reports in Hepatology. 2020. Vol. 2020, no. 2020, pp.1-2.
https://search.emarefa.net/detail/BIM-1147943
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1147943
